- Home
- RGNX vs GPRK Comparison
RGNX vs GPRK Comparison
Compare RGNX & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGNX | GPRK |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.5M | 649.0M |
| IPO Year | 2015 | 2009 |
Fundamental Metrics
Financial Performance| Metric | RGNX | GPRK |
|---|---|---|
| Price | $8.05 | $11.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $28.75 | $8.50 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $51.21 | $39.45 |
| Revenue Next Year | $19.08 | N/A |
| P/E Ratio | ★ N/A | $12.70 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $5.75 |
| 52 Week High | $16.19 | $13.13 |
Technical Indicators
Market Signals| Indicator | RGNX | GPRK |
|---|---|---|
| Relative Strength Index (RSI) | 37.32 | 54.53 |
| Support Level | $7.82 | $9.20 |
| Resistance Level | $9.67 | $11.77 |
| Average True Range (ATR) | 0.44 | 0.60 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 20.47 | 30.21 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About GPRK Geopark Ltd
GeoPark Ltd is an independent energy company. Its diversified portfolio of assets consist of Llanos 34 Block in Colombia, CPO-5 Block, Llanos 86, Llanos 87, Llanos 104, Llanos 123, and Llanos 124 Blocks in the Llanos Basin. Its segments include Colombia, Argentina, Brazil and Ecuador, with the majority of the revenue derived from Colombia. It derives revenue from Sale of crude oil, Sale of purchased crude oil, and Sale of gas.